TriNetX

Global health research network connecting biopharma with real-world patient data for trial feasibility.

TriNetX operates a global federated network of healthcare organizations providing access to real-world clinical data for clinical trial feasibility, patient recruitment optimization, and real-world evidence generation. Their platform spans over 120 healthcare organizations with data on hundreds of millions of patients globally.

Headquarters
Cambridge, United States
Founded
2015
Compliance
HIPAA, SOC 2 Type II, GDPR
Deployment options
cloud
Website
https://www.trinetx.com
LinkedIn
https://www.linkedin.com/company/trinetx

Categories

AI Use Cases

  • Patient Recruitment & Enrollment
  • Site Selection & Performance

Vendor Scorecard

100% — Complete coverage. Coverage score — how completely Atlas documents TriNetX across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Documented

HIPAA, SOC 2 Type II, GDPR

Deployment & Hosting — Documented

cloud

Pricing Transparency — Documented

Annual subscription by network access

Implementation & Onboarding — Documented

1–3 months

Organization & Role Fit — Documented

Biotech Startup, Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Academic / Research, Clinical Operations, R&D Leadership, Data Management

Solution Scope — Documented

Patient Recruitment, Real-World Evidence

Company Viability — Documented

Series C, $45.0M raised, 200+ employees, Founded 2015

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which health systems in our target geography are in the network?
  • How current is the patient data — what is the typical lag?
  • Can we see site-level data or only aggregate?
  • How do you handle patient consent for federated queries?